CRP (C-reactive protein) and IL-6 (interleukin-6) may be markers for type 2 diabetes:
This article was originally published in Clinica
Executive Summary
Elevated levels of two inflammatory proteins, C-reactive protein (CRP) and interleukin-6 (IL-6), may indicate an increased risk of type 2 diabetes, according to US researchers. Following suggestions that inflammation plays a role in the development of type 2 diabetes, Paul Ridker and colleagues at Harvard Medical School in Boston, Massachusetts, studied the levels of CRP and IL-6 in 27,628 women and followed them over a four-year period. 188 women developed type 2 diabetes, and among these, baseline levels of CRP and IL-6 were significantly higher than among those who did not.
You may also be interested in...
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.